[{"Assets_0_Q3_USD":159987000.0,"CommonStockSharesOutstanding_0_Q3_shares":13348124.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":29222000.0,"NetIncomeLoss_1_Q3_USD":-2682000.0,"NetIncomeLoss_3_Q3_USD":-2704000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":13203000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":13117000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":13203000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":13117000.0,"StockholdersEquity_0_Q3_USD":108745000.0,"EarningsPerShareBasic_1_Q3_USD":-0.2,"EarningsPerShareBasic_3_Q3_USD":-0.21,"EarningsPerShareDiluted_1_Q3_USD":-0.2,"EarningsPerShareDiluted_3_Q3_USD":-0.21,"Ticker":"SRDX","CIK":"924717","name":"SURMODICS INC","OfficialName":"Surmodics Inc. Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"609353600.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20180806"}]